Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of user safety, exposure and risk to veterinary medicinal products in the European Union.

Regulatory toxicology and pharmacology : RTP·2007
Same author

The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products.

Human & experimental toxicology·2005
Same author

Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.

Journal of veterinary pharmacology and therapeutics·2005
Same author

Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice -- the operation of a spontaneous reporting scheme in a European Union country -- the UK, and schemes in other countries.

Journal of veterinary pharmacology and therapeutics·2005
Same author

Veterinary pharmacovigilance. Part 3. Adverse effects of veterinary medicinal products in animals and on the environment.

Journal of veterinary pharmacology and therapeutics·2005
Same author

Veterinary pharmacovigilance. Part 4. Adverse reactions in humans to veterinary medicinal products.

Journal of veterinary pharmacology and therapeutics·2005

Related Experiment Video

Updated: May 28, 2026

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

Toxicity in animals: target species.

K N Woodward1

  • 1Technology Sciences (Europe) Limited, Concordia House, St James Business Park, Grimbald Crag Court, Knaresborough, North Yorkshire, HG5 8QB, UK. Kevin.Woodward@TSGEurope.com

Current Pharmaceutical Biotechnology
|November 2, 2011
PubMed
Summary

Macrocyclic lactones like ivermectin can cause neurotoxicity in animals, especially when misused or overdosed. Certain breeds are more susceptible due to a specific gene mutation affecting drug penetration in the brain.

More Related Videos

Protocol for Acute and Chronic Ecotoxicity Testing of the Turquoise Killifish Nothobranchius furzeri
09:43

Protocol for Acute and Chronic Ecotoxicity Testing of the Turquoise Killifish Nothobranchius furzeri

Published on: April 24, 2018

Cytotoxicity Assays with Zebrafish Cell Lines
08:22

Cytotoxicity Assays with Zebrafish Cell Lines

Published on: January 6, 2023

Related Experiment Videos

Last Updated: May 28, 2026

Lethality Bioassay Using Artemia salina L.
09:09

Lethality Bioassay Using Artemia salina L.

Published on: October 11, 2022

Protocol for Acute and Chronic Ecotoxicity Testing of the Turquoise Killifish Nothobranchius furzeri
09:43

Protocol for Acute and Chronic Ecotoxicity Testing of the Turquoise Killifish Nothobranchius furzeri

Published on: April 24, 2018

Cytotoxicity Assays with Zebrafish Cell Lines
08:22

Cytotoxicity Assays with Zebrafish Cell Lines

Published on: January 6, 2023

Area of Science:

  • Veterinary Pharmacology
  • Toxicology
  • Genetics

Background:

  • Macrocyclic lactones, such as ivermectin, are widely used endectocides.
  • While safe and effective when used as directed, off-label use, misuse, or overdosing can lead to toxicity in animal patients.
  • Pharmacovigilance data highlights neurotoxic effects as common adverse drug reactions in overdosed animals.

Purpose of the Study:

  • To investigate the neurotoxic effects of macrocyclic lactones in animal patients.
  • To identify factors contributing to enhanced sensitivity to macrocyclic lactone toxicity.
  • To understand the genetic basis of P-glycoprotein deficiency and its role in adverse drug reactions.

Main Methods:

  • Review of pharmacovigilance data to identify clinical signs of toxicity.
  • Preclinical toxicity studies in animal models.
  • Genetic analysis to identify mutations in the MDR1 gene associated with P-glycoprotein deficiency.

Main Results:

  • Neurotoxic effects are the primary clinical signs observed in animals overdosed with macrocyclic lactones.
  • Specific subpopulations of certain species exhibit heightened sensitivity to these neurotoxic effects.
  • This sensitivity is linked to enhanced drug penetration into the brain due to a deficiency in P-glycoprotein, often caused by an MDR1 gene mutation.

Conclusions:

  • Misuse and overdosing of macrocyclic lactones can result in significant neurotoxicity in animals.
  • Genetic variations, specifically MDR1 gene mutations leading to P-glycoprotein deficiency, predispose certain animal populations to severe adverse drug reactions.
  • Understanding these genetic factors is crucial for safe and effective use of macrocyclic lactones in veterinary medicine.